MIRA PHARMACEUTICALS, INC.
MIRA PHARMACEUTICALS, INC. (MIRA): 3 pipeline candidates · ~23 mo cash runway · 3 clinical trials. Updated within the last hour.
BioSniper Score
4-factor signal · derived from public data
22.9 months
D/E 0.01 · 0% dilution
Lead: Phase 1
3 candidates
N/A
N/A
A transparent, data-derived signal for MIRA PHARMACEUTICALS, INC.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$39.2M
Cash
$4.8M
Quarterly Burn
$1.2M
Runway
22.9 mo
Revenue
—
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Pipeline (3 candidates)
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
25
Total value held
$2.9M
| Holder | Shares | Value |
|---|---|---|
| vanguard capital management llc | 1,387,824 | $1.5M |
| cross staff investments inc | 359,401 | $385K |
| geode capital management, llc | 290,890 | $311K |
| vanguard fiduciary trust co | 169,483 | $181K |
| blackrock, inc. | 112,346 | $120K |
| northern trust corp | 67,698 | $72K |
| first american bank | 60,000 | $64K |
| state street corp | 49,100 | $53K |
| xtx topco ltd | 37,573 | $40K |
| commonwealth equity services, llc | 35,067 | $38K |
Showing top 10 of 25 institutional holders of MIRA PHARMACEUTICALS, INC.. Sign up for the full 13F holder list and quarter-by-quarter ownership history.
Frequently asked questions
How many drug candidates are in MIRA PHARMACEUTICALS, INC.'s pipeline?
MIRA PHARMACEUTICALS, INC. (MIRA) has 3 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.
What is MIRA PHARMACEUTICALS, INC.'s lead drug candidate?
MIRA PHARMACEUTICALS, INC.'s most advanced tracked candidate is ketamir-2 (Phase 1) for diabetic neuropathy, neuropathic pain, treatment-resistant depression (TRD), major depressive disorder with suicidal ideation (MDD-SI), and post-traumatic stress disorder (PTSD).
What is MIRA PHARMACEUTICALS, INC.'s cash runway?
Based on its most recent reported cash balance and quarterly burn rate, MIRA PHARMACEUTICALS, INC. has approximately 22.9 months of cash runway.
What is MIRA PHARMACEUTICALS, INC.'s market capitalization?
MIRA PHARMACEUTICALS, INC.'s market capitalization is approximately $39.2M.
Who is the CEO of MIRA PHARMACEUTICALS, INC.?
Mr. Erez Aminov is the chief executive officer of MIRA PHARMACEUTICALS, INC. (MIRA).
Get the full picture on MIRA PHARMACEUTICALS, INC.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.